PRE-DELIRIC Prediction Model Plus SMART Care to Reduce the Incidence of Delirium in ICU Patients
Effectiveness of PRE-DELIRIC-Guided SMART/SmART Care in Reducing Delirium Incidence Among Surgical Intensive Care Unit Patients
1 other identifier
observational
381
1 country
1
Brief Summary
Delirium is a severe acute brain dysfunction characterised by sudden confusion, inattention and fluctuating level of consciousness, which mainly affects intubated intensive care patients. It increases the risk of self-extubation, prolongs ICU stay and increases mortality. The incidence of delirium in ICUs varies, with approximately 33.3% of patients affected, and rates of new-onset and pre-existing delirium range from 4% to 89%. Accurate diagnosis is challenging, with 60-80% of patients remaining undiagnosed. Early detection is critical for intervention and improved outcomes. To address these issues, the PREdiction of DELIRium (PRE-DELIRIC) model incorporates 10 risk factors and predicts delirium within 24 hours of ICU admission, allowing risk stratification into low to very high risk categories. It recalibrates predictive values with a sensitivity of 91.3% and specificity of 64.4% using a cut-off score of 27%. However, its integration into delirium management is underexplored. Delirium risk stratification supports efficient resource allocation, cost control, workload reduction and ethical care, while promptly identifying high-risk patients. In this study, Investigators evaluate the integration of the PRE-DELIRIC model into a comprehensive delirium management approach called PRE-DELIRIC-guided SMART/SmART care. SMART care includes improving familiarity, assessing pain and anxiety, reducing equipment discomfort and cognitive stimulation. Patients with PRE-DELIRIC scores \>30% receive SMART care and multidisciplinary involvement, based on the American Delirium Society.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2023
CompletedFirst Submitted
Initial submission to the registry
November 12, 2023
CompletedFirst Posted
Study publicly available on registry
February 28, 2024
CompletedFebruary 28, 2024
June 1, 2023
5 months
November 12, 2023
February 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
the incidence of delirium
The incidence of delirium which was assessed by each shift primary ICU nurse by using the ICDSC.
duration of ICU stay (postoperative 30 days)
Secondary Outcomes (5)
duration of ventilator use
duration of ICU stay( (postoperative 30 days)
rate of unplanned self-extubation
duration of intubation( (postoperative 30 days)
day of physical restraint
duration of ICU stay (postoperative 30 days)
level of mobility
duration of ICU stay (postoperative 30 days)
cumulative dose of sedatives
duration of ICU stay (postoperative 30 days)
Eligibility Criteria
The inclusion criteria encompass patients admitted to a surgical ICU in Taipei, Taiwan, from January 2021 to March 2023.
You may qualify if:
- \. SICU patients are over 18 years old. 2. received surgery intervention
You may not qualify if:
- Clinical diagnosis of mental disorders
- Underwent neurosurgical procedures,
- Discharged from the ICU within 24 hours of admission
- Transitioned to active life support withdrawal or "comfort care only" within 24 hours of ICU admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
Study Officials
- PRINCIPAL INVESTIGATOR
Wei Ling Hsiao, Master
National Taiwan University Hospital
- STUDY DIRECTOR
Man-Ling Wang, Doctor
National Taiwan University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2023
First Posted
February 28, 2024
Study Start
June 8, 2023
Primary Completion
October 30, 2023
Study Completion
October 30, 2023
Last Updated
February 28, 2024
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share